BGI Genomics Co., Ltd. (SHE:300676)
China flag China · Delayed Price · Currency is CNY
38.71
-0.17 (-0.44%)
Sep 1, 2026, 3:04 PM CST

BGI Genomics Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
3,8623,7053,8674,3507,0536,766
Revenue Growth
6.46%-4.18%-11.10%-38.33%4.24%-19.42%
Gross Profit
1,2821,2701,5032,1473,5263,921
Operating Income
-482.18-594.78-736.64112.94905.271,680
Net Income
-575.04-616.66-902.6992.9802.771,462
Earnings Per Share
-1.38-1.48-2.190.231.963.55
EPS Growth
----88.48%-44.90%-32.25%

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Mainland China (Excluding Hong Kong, Macau and Taiwan)
3,3343,1343,3063,4593,6292,885
Europe and Africa
236.75224.64224.63216.81388.52938.75
Americas
48.9359.8390.32116.15244.71432.13
Asia (Including China, Hong Kong, Macau, and Taiwan) and Oceania
242.04286.43245.94557.562,7912,511
Total
3,8623,7053,8674,3507,0536,766

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
3,1633,7784,3105,5096,4038,646
Total Debt
527.94636.85471.27365.4200.01847.75
Net Cash (Debt)
2,6353,1413,8385,1446,2037,798
Net Cash Growth
-18.36%-18.17%-25.38%-17.07%-20.46%89.68%
Net Cash Per Share
6.327.549.3112.4715.1218.94

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
73.57-63.2195.72408.77130.882,476
Capital Expenditures
-491.12-505.92-529.48-1,236-1,267-383.52
Free Cash Flow
-417.55-569.14-433.76-827.62-1,1362,093
Free Cash Flow Growth
------36.62%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
33.18%34.27%38.87%49.37%49.99%57.95%
Operating Margin
-12.49%-16.05%-19.05%2.60%12.83%24.83%
Pretax Margin
-13.74%-16.26%-22.92%2.66%14.27%25.80%
Profit Margin
-14.89%-16.64%-23.34%2.14%11.38%21.60%
FCF Margin
-10.81%-15.36%-11.22%-19.03%-16.10%30.93%

Dividends

Fiscal YearFY 2023FY 2022FY 2021
Period EndingDec '23 Jan '23 Jan '22
Dividend Per Share
0.1001.0000.350
Dividend Per Share Growth
-90.00%185.71%0%
Dividend Yield
0.21%1.97%0.41%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
---211.8026.3924.63
Forward PE
144.0025.0925.0925.0925.0935.26
P/FCF Ratio
-----17.20
PS Ratio
3.864.704.144.523.005.32